2014-01-14 New York Times: In an innovative new partnership with a regional healthcare provider, Regeneron Pharmaceuticals, a collaborator in the KOMP program, has launched an effort to identify new druggable targets linked to human diseases.
2014-01-14 New York Times: In an innovative new partnership with a regional healthcare provider, Regeneron Pharmaceuticals, a collaborator in the KOMP program, has launched an effort to identify new druggable targets linked to human diseases.